Neogen (NEOG) Shares Outstanding (Weighted Average) (2010 - 2026)
Neogen (NEOG) recorded quarterly Shares Outstanding (Weighted Average) of $217.7 million in Q1 2026, little changed quarter-over-quarter from $217.4 million in Q4 2025, and little changed on a YoY basis from $217.0 million in Q1 2025.
Neogen (NEOG) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends
Neogen's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $217.7 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) changed 0.31% year-over-year to $217.7 million; the TTM figure through Feb 2026 stood at $217.7 million (changed 0.31% YoY), while the FY2025 annual figure was $216.9 million, changed 0.19% from the prior year.
- Shares Outstanding (Weighted Average) was $217.7 million for Q1 2026 at Neogen, roughly flat from $217.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $217.7 million in Q1 2026 to a low of $107.7 million in Q2 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $192.7 million across 5 years, with a median of $216.5 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) surged 100.59% in 2023, then gained 0.18% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $161.7 million in 2022, then soared by 33.81% to $216.4 million in 2023, then increased by 0.21% to $216.8 million in 2024, then grew by 0.27% to $217.4 million in 2025, then advanced by 0.12% to $217.7 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $217.7 million (Q1 2026), $217.4 million (Q4 2025), and $217.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | 217.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 217.67 Mn |
| Nov 30, 2025 | 217.41 Mn |
| Aug 31, 2025 | 217.22 Mn |
| May 31, 2025 | 216.89 Mn |
| Feb 28, 2025 | 217.00 Mn |
| Nov 30, 2024 | 216.81 Mn |
| Aug 31, 2024 | 216.70 Mn |
| May 31, 2024 | 216.48 Mn |
| Feb 29, 2024 | 216.60 Mn |
| Nov 30, 2023 | 216.36 Mn |
| Aug 31, 2023 | 216.31 Mn |
| May 31, 2023 | 188.88 Mn |
| Feb 28, 2023 | 216.22 Mn |
| Nov 30, 2022 | 161.69 Mn |
| Aug 31, 2022 | 107.84 Mn |
| May 31, 2022 | 107.68 Mn |
| Feb 28, 2022 | 107.82 Mn |
| Nov 30, 2021 | 107.57 Mn |
| Aug 31, 2021 | 107.49 Mn |
| May 31, 2021 | 106.50 Mn |